CompletedPHASE1, PHASE2NCT04289194

Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Histocell, S.L.
Principal Investigator
Fermin Labayen Beraza, MD, M.D
Hospital de Cruces
Intervention
HCR040 (Phase 1)(drug)
Enrollment
26 enrolled
Eligibility
18 years · All sexes
Timeline
20192022

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04289194 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials